The Investment Column: JJB is still goal-orientated, but investors say it's a long-ball game, not a quick net result

Alizyme; Premier Oil


Our view: Sell

Share price: 124.25p (-3p)

Wigan Athletic football club, which is sponsored by retailer JJB Sports, narrowly avoided relegation from the premiership this season. Sadly for JJB, the team is about the only thing that is not going down.

At an initial glance, there is very little in JJB to commend to investors. Sales were down 8 per cent in the 13 weeks to the end of April, according to yesterday's trading update; revenues were down 8.3 per cent.

On a valuation basis, things do not look much better. According to analysts at Dresdner Kleinwort, JJB trades at 14 times estimated 2009 earnings, which is a premium to a host of retail stocks including Clinton Cards, Halfords and Mothercare. The group's gearing is so high that a 1 per cent change in sales leads to a 10 per cent move in operating profit. In short, things are not looking that great, particularly as most observers reckon that the country's economic problems are not going away any time soon.

All bad news, then? Well, not so fast. Yes, the group is toiling and investors would be crazy to buy the stock hoping for an immediate return. But the analysts at Dresdner still have the group at hold, saying that the potential recovery story is good. The group has closed loss-making stores, especially in areas where the company has out-of-town shops and is trying to avoid being an entirely retail entity by opening a series of health centres. Furthermore, JJB, which has previously relied on the major summer football tournaments to sell replica shirts, is trying to rid itself of that model, which is just as well given that England will be conspicuous by its absence from this summer's European championships.

Investors should also be buoyed by the fact that the group is 22.3 per cent owned by Icelandic fund Exista, and while they are not expected to launch a takeover bid, the holding should provide a backstop against the shares falling through the floor.

The recovery story is good. But recovery has not started yet and analysts are still complaining about a lack of visibility. JJB might be a solid, longer-term punt, but not for now. Sell.

Alizyme

Our view: Buy

Share price: 26.5p (-1.5p)

For biotech firms to go from a being a small scientific organisation to a successful pharmaceutical group (or more likely, be bought up a pharma giant) they need some of their ideas to succeed. And that is why the stock was sent spiralling on news in April that Alizyme's treatment for irritable bowel syndrome, Renzapride, had failed its phase-three trial.

The group's shares have been on a downward trajectory since, after hitting year highs of 105p last June. However, observers are not as downbeat as you might expect. True, those at Investec, who revised their price target from 41p to 59p on the bad Renzapride news, say that given where the shares trade, the stock is theoretically a hold.

However, the analysts advise clients to buy the stock. The reason is the group's other potential blockbuster, the anti-obesity and type 2 diabetes drug Celilistat, which is expected to win "a major licensing deal... in the near future. We therefore recommend buying on weakness", they say.

Finn Capital points out that the group has raised £10m from institutional lenders to remain a going concern and, "this demonstrates institutional confidence in Alizyme's ability to deliver", they reckon.

The truth is that buying into smaller biotech companies is always a punt. Those with a nervous disposition should avoid the sector that depends largely on companies with sound ideas transforming good science into a commercially viable treatment. The failure list is long.

However, while analysts are all too happy to point out a basket case when they see one, none ascribes that moniker to Alizyme, which is also set to receive third phase results on another treatment, Colal-Pred, for ulcerative colitis, in July.

Biotech valuations are largely driven by news flow. Alizyme is expecting lots in the next few months, and most of it is likely to be good. Buy.

Premier Oil

Our view: Buy

Share price: 1738p (-9o)

Back in March, The Investment Column suggested that buyers should back Premier Oil at 1343p. And despite the jump in the stock since then, investors would still be well-advised to get more.

With the black stuff at almost $130 a barrel and rising, most oil companies are doing well. Tullow Oil's shares jumped massively a couple of weeks ago on news that it had confirmed a major new find off Ghana.

The same could well be about to happen to Premier Oil. In a trading update, the group yesterday revised its target of 50,000 barrels a day (bpd) to 80,000 bpd by 2012, saying that its exploration activities in Vietnam, in an area where the group has done well in the past, were on course.

Analysts at Evolution Securities, who are in the process of upgrading their estimates, say that a strong news flow, coupled with the high oil price, will drive the stock up. The group, they say is still cheap compared to the sector, which includes companies such as Tullow and Cairn Energy. Buy.

News
Russell Brand was in typically combative form during his promotional interview with Newsnight's Evan Davis
peopleReports that Brand could stand for Mayor on an 'anti-politics' ticket
News
The clocks go forward an hour at 1am on Sunday 30 March
news
Arts and Entertainment
The Doctor finds himself in a forest version of London in Doctor Who episode 'In the Forest of the Night'
TVReview: Is the Doctor ever going stop frowning? Apparently not.
News
Voluminous silk drawers were worn by Queen Victoria
newsThe silk underwear is part of a growing trade in celebrity smalls
PROMOTED VIDEO
Sport
footballMatch report: Real fight back to ruin Argentinian's debut
News
Candidates with surnames that start with an A have an electoral advantage
newsVoters are biased towards names with letters near start of alphabet
Arts and Entertainment
Isis with Lord Grantham (Hugh Bonneville)
TV
Arts and Entertainment
Jay James
TVReview: Performances were stale and cheesier than a chunk of Blue Stilton left out for a month
News
ebooksAn unforgettable anthology of contemporary reportage
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Compensation and Benefits Manager - Brentwood - Circa £60,000

£60000 per annum: Ashdown Group: Compensation and Benefits Manager - Compensat...

Data Analyst/Planning and Performance – Surrey – Up to £35k

£30000 - £35000 Per Annum plus excellent benefits: Clearwater People Solutions...

IT Systems Business Analyst - Watford - £28k + bonus + benefits

£24000 - £28000 per annum + bonus & benefits: Ashdown Group: IT Business Syste...

Markit EDM (CADIS) Developer

£50000 - £90000 per annum + benefits: Ampersand Consulting LLP: Markit EDM (CA...

Day In a Page

Wilko Johnson, now the bad news: musician splits with manager after police investigate assault claims

Wilko Johnson, now the bad news

Former Dr Feelgood splits with manager after police investigate assault claims
Mark Udall: The Democrat Senator with a fight on his hands ahead of the US midterm elections

Mark Udall: The Democrat Senator with a fight on his hands

The Senator for Colorado is for gay rights, for abortion rights – and in the Republicans’ sights as they threaten to take control of the Senate next month
New discoveries show more contact between far-flung prehistoric humans than had been thought

New discoveries show more contact between far-flung prehistoric humans than had been thought

Evidence found of contact between Easter Islanders and South America
Cerys Matthews reveals how her uncle taped 150 interviews for a biography of Dylan Thomas

Cerys Matthews on Dylan Thomas

The singer reveals how her uncle taped 150 interviews for a biography of the famous Welsh poet
DIY is not fun and we've finally realised this as a nation

Homebase closures: 'DIY is not fun'

Homebase has announced the closure of one in four of its stores. Nick Harding, who never did know his awl from his elbow, is glad to see the back of DIY
The Battle of the Five Armies: Air New Zealand releases new Hobbit-inspired in-flight video

Air New Zealand's wizard in-flight video

The airline has released a new Hobbit-inspired clip dubbed "The most epic safety video ever made"
Pumpkin spice is the flavour of the month - but can you stomach the sweetness?

Pumpkin spice is the flavour of the month

The combination of cinnamon, clove, nutmeg (and no actual pumpkin), now flavours everything from lattes to cream cheese in the US
11 best sonic skincare brushes

11 best sonic skincare brushes

Forget the flannel - take skincare to the next level by using your favourite cleanser with a sonic facial brush
Paul Scholes column: I'm not worried about Manchester United's defence - Chelsea test can be the making of Phil Jones and Marcos Rojo

Paul Scholes column

I'm not worried about Manchester United's defence - Chelsea test can be the making of Jones and Rojo
Frank Warren: Boxing has its problems but in all my time I've never seen a crooked fight

Frank Warren: Boxing has its problems but in all my time I've never seen a crooked fight

While other sports are stalked by corruption, we are an easy target for the critics
Jamie Roberts exclusive interview: 'I'm a man of my word – I'll stay in Paris'

Jamie Roberts: 'I'm a man of my word – I'll stay in Paris'

Wales centre says he’s not coming home but is looking to establish himself at Racing Métro
How could three tourists have been battered within an inch of their lives by a burglar in a plush London hotel?

A crime that reveals London's dark heart

How could three tourists have been battered within an inch of their lives by a burglar in a plush London hotel?